PMGC unit NorthStrive Biosciences partners with Charles River to advance EL-22, EL-32 programs

Bitget2026/09/29 11:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

PMGC Holdings’ NorthStrive Biosciences signed a statement of work with Charles River Laboratories to support EL-22 and EL-32 development.
Charles River will run analytical testing to quantify plasmid copy number for NorthStrive’s engineered bacterial product candidates.
Data is intended to support product identity, manufacturing consistency, comparability, and NorthStrive’s push toward an IND-enabling framework.
Work supports NorthStrive’s engineered probiotic platform targeting muscle preservation, including in patients using GLP-1 weight-loss treatments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290733PRIMZONEFULLFEED9835694) on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

PMGC unit NorthStrive Biosciences partners with Charles River to advance EL-22, EL-32 programs

You may also like

Crypto prices